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SINTESIS, PENCIRIAN, KAJIAN BELAHAN DNA OKSIDATIF DAN 
PENGIKATAN DNA UNTUK KOMPLEKS KUPRUM (II) LIGAN 
CAMPURAN 
 
ABSTRAK 
Sebanyak enam kompleks kuprum(II) ternari bagi asid amino dan ligan polipiridil 
dengan formula am [Cu(AA)(B) Cl]·nH2O atau [Cu(AA)(B)(H2O)]Cl·nH2O, di mana 
AA = DL-threonina, DL-fenilalanina, dan DL-valina; B = 2,2’-bipiridil, 4,4’-
dimethyl-2,2’-dipiridil, dan 1,10-fenantrolina telah disintesiskan. Kompleks ini telah 
dicirikan dengan analisis unsur CHN, AAS, FT-IR dan UV-Vis serta struktur 
kompleks ini telah ditentukan secara kristalografi sinar-X. Semua kompleks 
membentuk geometri koordinatan piramid segiempat terherot. Spektrum penyerapan 
elektronik bagi kompleks ini menunjukkan keamatan d-d jalur elektronik yang sangat 
rendah dengan julat 600-635 nm di dalam Tris-HCl/NaCl (5:5 mM) pH 7.2 larutan 
tampan. Interaksi pengikatan DNA dengan CT-DNA telah dikaji oleh spektrum 
titratan penyerapan elektronik dan pengukuran kelikatan. Keputusan menunjukkan 
bahawa kompleks fenantrolina berinteraksi dengan CT-DNA melalui interkalasi 
manakala kompleks bipiridil mengikat CT-DNA melalui mod pengikatan alur. 
Pemalar pengikatan intrinsik (Kb) yang dikira bagi semua kompleks adalah dalam 
julat 0.5-6.2 × 10
5
 M
-1
. Semua kompleks kuprum(II) didapati mempamerkan aktiviti 
belahan DNA yang efisien pada kepekatan yang rendah dengan kehadiran H2O2. 
Kajian menunjukkan bahawa [Cu(Phe)(Phen) Cl]·3H2O mempamerkan pengikatan 
DNA dan aktiviti nukleasa yang paling tinggi dalam kalangan enam kompleks 
kuprum(II). 
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SYNTHESIS, CHARACTERIZATION, OXIDATIVE DNA CLEAVAGE AND 
DNA BINDING STUDIES OF MIXED LIGANDS COPPER(II) COMPLEXES 
 
ABSTRACT 
Six ternary copper(II) complexes of amino acids and polypyridyl ligands with a 
general formula of [Cu(AA)(B) Cl]·nH2O or [Cu(AA)(B)(H2O)]Cl·nH2O, where AA 
= DL-threonine, DL-phenylalanine, and DL-valine; B = 2,2’-bipyridyl, 4,4’-
dimethyl-2,2’-dipyridyl, and 1,10-phenanthroline are synthesized. The complexes are 
characterized by CHN elemental analysis, AAS, FT-IR, and UV-Vis and have been 
structurally characterized by X-ray crystallography. All the complexes formed 
slightly distorted square-pyramidal coordination geometries. The electronic 
absorption spectra of the complexes show very low intensity of d-d electronic band 
in the range of 600-635 nm in Tris-HCl/NaCl (5:5 mM) pH 7.2 buffer solution. The 
DNA binding interaction with CT-DNA has been investigated by electronic 
absorption spectral titration and viscosity measurements. The results revealed that the 
phenanthroline complexes interact with CT-DNA through intercalation while 
bipyridyl complexes bind to CT-DNA through groove binding mode. The calculated 
intrinsic binding constant (Kb) of all the complexes are in the range of 0.5-6.2 × 10
5
 
M
-1
. All the copper(II) complexes are found to promote efficient DNA cleavage 
activities at low concentration in the presence of H2O2. The studies show that 
[Cu(Phe)(Phen)Cl]·3H2O exhibits the highest DNA binding and nuclease activity 
among the six copper(II) complexes. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Cancer diseases 
Cancer can be defined as a disease which cells in the body grow or divide 
uncontrollably and the ability of these cells to invade other tissues within the body 
(What, 2013). The cells migrate through lymph and blood system to other part of the 
body.  If the spread of the cells is not controlled, it can cause death. In another 
meaning, cancer is a disease of gene which is a small part of DNA, whereas DNA is 
the master molecules of the cells. Majority of the cancer are caused by changes in the 
cell’s DNA through mutation which disrupt the normal function of the gene to 
produce protein. As a result, these cells become abnormal and divided uncontrollably. 
In Malaysia, the cancer disease is growing in a worrying trend.  Among all 
the medically certified deaths, it ranks number four. The annual incidence of cancer 
is estimated to be around 30000 cases. However, the incidence of cancer is expected 
to increase due to aging populations. It was reported that there is 4.6 % of people 
aged 60 above were diagnosed with cases in 1957, the number increased to 5.7 % in 
1990 and estimated to reach 9.8 % in 2020 (Lim, 2002). 
 
1.1.1 An introduction to Deoxyribonucleic Acid (DNA) 
Deoxyribonucleic acid (DNA) was discovered serendipitously by a Swiss 
chemist, Friederich Miescher in 1869, when he tried to determine the chemical 
composition of the cells. DNA is a nucleic acid that functions as the hereditary 
material in humans and almost all the other organisms. Besides RNA and protein, 
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DNA is among the three major macromolecules that are vital to the earth's ecosystem. 
Most of the DNA located in the cell nucleus (nuclear DNA) and a small amount of 
DNA can be found in the mitochondria (mitochondrial DNA).  
Basically, double helix DNA consists of two complimentary long polymeric 
chains of simple units called nucleotides which twisted against each other, with 
backbones made of sugar residues and phosphate groups joined by ester bonds. 
Nucleotides are the building blocks of nucleic acids. These two DNA strands run in 
anti-parallel directions which always assembled in the 3’ to 5’ direction. A 
phosphodiester linkage exists between a phosphate group on one nucleotide and the 
sugar molecule on the adjacent nucleotide. The DNA double helix is stabilized by 
hydrogen bonds between the nucleotides and the base-stacking interaction among the 
aromatic nucleobases.  
The sequence of the four nucleobases along the backbone encodes the 
hereditary information. The information in DNA is stored as a code and read using 
the genetic code, which specifies the sequence of the amino acids within proteins. 
The code is made up of four chemical bases, that is, adenine (A), cytosine (C), 
guanine (G) and thymine (T). These four nitrogen-containing bases are divided into 
purines (adenine and guanine) and pyrimidines (cytosine and thymine). Adenine 
binds to thymine and guanine binds to cytosine to form a complementary base pair. 
Each base pair is attached to a sugar molecule and a phosphate molecule to form a 
complete nucleotide. 
The sugar phosphate backbone of paired strands defines the helical grooves, 
within which the edges of the heterocyclic bases are exposed. These grooves are 
adjacent to the base pairs and may provide a binding site. The biologically relevant 
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B-form structure of the DNA double helix is characterized by a shallow, wide major 
groove and a deep, narrow minor groove where both grooves offer a number of 
hydrogen binding sites. The chemical structure of a DNA double helix is illustrated 
in Figure 1.1. 
Numerous reports suggested that DNA is the primary intracellular target for 
most of the anticancer and antiviral therapies according to cell biologist (Kumar et 
al., 2008a). The interaction between DNA and small molecules through binding can 
lead to DNA damage in cancer cells, blocking the distribution and growth of cancer 
cells, hence resulting in the cancer cell death. This damage could cause major 
pathological changes in living organisms (Kumar & Arunachalam, 2009). Therefore, 
it is vital to develop potential anticancer agents that are capable of binding and 
cleaving DNA under physiological conditions (Rajendiran et al., 2007; Raman & 
Selvan, 2011; Chen et al., 2011; Kashanian et al., 2012). 
 
 
Figure 1.1: Chemical structure of a DNA double helix (DNA, 2011) 
Nucleotide bases 
Sugar phosphate backbone 
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1.2 Background of nucleolytic activity of transition metal complexes 
The DNA cleavage process is regarded as one of the vital process in the 
ecosystem. The function of anticancer drugs is its capability to cause damage to cells 
such as bleomycin in the DNA. This damage can cause apoptosis which leads to the 
death of the affected cell. (Chen & Stubbe, 2005). 
Transition metal nucleolytic activity has undergone intensive studies which 
lead to the breakthrough in effective interaction of anticancer agents with DNA and 
further induces DNA cleavage in the presence of co-factor. The research on 
nucleolytic activity is very important in attaining the formation of DNA sequence 
and forbidding the replication of cancer cell (Yang et al., 2004a). Several transition 
metal complexes such as copper, ruthenium, cobalt, zinc, nickel, vanadium and 
manganese complexes have been reported to exhibit DNA cleavage activities. Such 
complexes could interact with DNA and promote the breakage of DNA strands by 
applicable methods. For instance, the DNA double strands of cancer genes break 
after the strands are cleaved and the capability for replication of cancer gene is 
damaged (Raman et al., 2007). 
In order to monitor the progress of DNA cleavage by transition metal 
complexes, agarose gel electrophoresis is the most common method applied in 
biochemistry and molecular biology to demonstrate damage incurred on DNA. 
Plasmid pBR322 DNA is one of the commonly used DNA strains which is a double 
helix DNA and exists in supercoiled form. In general, the supercoiled DNA (Form I) 
will relax and convert to nicked form (Form II) when the DNA scission occurs in one 
strand of the supercoiled DNA. On the other hand, if the DNA scission takes place 
on both strands, a linear form (Form III) will be generated. These three forms exhibit 
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different migration rate in the gel electrophoresis (Figure 1.2). The supercoiled form 
will be the fastest to migrate while the nicked form is the slowest. The linear form 
migrates in the intermediate which is between supercoiled and nicked forms. The 
movement of DNA bands is achieved by moving the negatively charged nucleic acid 
molecules through an agarose gel matrix with the application of an electric field 
(electrophoresis). 
The efficiency of DNA cleavage is varied with some complexes able to 
induce both single and double strand scissions whereas some complexes can only 
bring about single scission. Generally, DNA cleavage can be categorized in three 
different types which are hydrolytic DNA cleavage, photochemical DNA cleavage 
and oxidative DNA cleavage (Li et al., 2010). Photochemical and oxidative DNA 
cleavages are quite closely related. 
 
Figure 1.2: Supercoiled, nicked and linear DNA bands in gel electrophoresis 
diagram 
 
1.2.1 Hydrolytic DNA cleavage 
Hydrolytic DNA cleavage involves the hydrolysis of phosphodiester bond. 
The transition metal complexes can promote DNA cleavage directly by cleaving the 
P-O bond in phosphodiester of DNA, leading to fragmentation of DNA which could 
be then religated. Hydrolytic cleavage can occur without any reductants or oxidants. 
The active species of hydrolytic cleavage are capable of mimicking restriction 
enzymes.  
Form II 
(nicked) 
Form III 
(linear) 
Form I 
(supercoiled) 
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The hydrolysis reaction is made possible by the existence of Lewis acids 
which in the case is the metal ions. The function of these Lewis acids is to activate 
the phosphate group towards the nucleophilic attack, where Lewis acids withdraw 
the electron and weakening the P-O bond, water or hydroxide acts as nucleophile to 
attack and break the bond. Generally, the DNA hydrolysis reaction mechanism is the 
nucleophilic attack. The nucleophile attacked the DNA phosphate backbone which 
resulted in the formation of five coordinate intermediates. These intermediates will 
be stabilized by the catalyst as shown in Figure 1.3. As for subsequent cleavage of 
either the 3’-PO or the 5’-PO, it will result in a strand scission (Mancin et al., 2005). 
Among the transition metal complexes that are used as synthetic hydrolases, 
zinc(II) and copper(II) are suitable for hydrolytic DNA cleavage owing to their 
strong Lewis acid properties. Li and co-workers studied the DNA cleavage activity 
of four new copper(II) complexes and found that all complexes could cleave plasmid 
DNA effectively through hydrolytic pathway (Li et al., 2010). 
 
Figure 1.3: Proposed reaction mechanism for the hydrolytic cleavage of DNA  
       (Mancin et al., 2005) 
 
 
1.2.2 Photochemical DNA cleavage 
Photochemical cleavage of DNA is a type of oxidative DNA cleavage on 
photoirradiation which plays a significant role in photodynamic therapy (PDT) of 
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cancer (Patra et al., 2007; Sasmal et al., 2007). It can be categorized into two types 
which are the DNA cleavage through the generation of reactive oxygen species 
(ROS), or by photochemical means and direct UV-induced DNA damage. The later 
induced DNA damage happens through the formation of mutagenic and cytotoxic 
DNA lesions. This formation is possible due to the presence of two pyrimidine 
residues which are thymine and cytosine. Both the pyrimidine residues react through 
a direct UV-promoted dimerization.  (Sinha & Häder, 2002).  
In the oxidative and photochemical DNA cleavage, reactive intermediates are 
produced, which are the two similar pyrimidine residues. As for the photochemical 
DNA cleavage, either the metal complexes or the organic compounds are responsible 
for producing the reactive intermediates. In most of the situation, DNA-cleaving 
agents produce extremely reactive intermediates that cause damage to DNA. DNA 
cleaving agents itself neither directly responsible nor attack on the DNA (Burrows & 
Muller, 1998). In turn, strand scission happens in results of the auto-oxidation 
reactions from the damaged DNA.  
There are two types of DNA damage initiated by photosensitization (Figure 
1.4), a one electron process (Type I process) and a pathway involving singlet oxygen 
(Type II process). In the Type I process, through the excitation of the cleaving agent, 
it generates sequentially a superoxide radical from molecular oxygen via an electron 
transfer step. Due to the properties of superoxide which is a poor oxidant, it could act 
as a strong reductant. The DNA damage observed through this pathway is mainly 
guanine oxidation, formed via guanine radical cations. This results in the formation 
of base labile sites in the DNA. In a Type II process, a contrast to superoxide, the 
photo excited compound generates singlet oxygen, which modifies guanine residues. 
There are two pathways that can be distinguished in Type II process (Figure 1.5). A 
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Diels-Alder reaction with singlet oxygen results in the formation of 4,8-digydro-4-
hydroxy-8-oxo-dG, and further reduction in 8-oxo-dG. A [2+2] cycloaddition with 
singlet oxygen results after a cascade of reactions in the formation of cyanuric acid. 
The modified residues are base labile positions in the DNA and alkaline work-up is 
required to initiate strand breaks (Paillous & Vicendo, 1993). 
 
 
 
 
Figure 1.4: Type I and Type II photochemical cleavage of DNA (Paillous &  
        Vicendo, 1993) 
 
Figure 1.5: Different reaction pathways of guanine with singlet oxygen (Paillous & 
        Vicendo, 1993) 
DNA cleaving agent 
Photosensization 
[DNA cleaving agent]* 
O2ˉ 
1
O2 
Guanine oxidation 
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1.2.3 Oxidative DNA cleavage in the presence of H2O2/MPA/Ascorbic acid 
In oxidative DNA cleavage, a transition metal complex cannot induce the 
cleavage activity directly but indirectly through generating ROS by a redox active 
metal complex such as hydroxyl radical and singlet (Jiang et al., 2007). Oxidative 
DNA cleavage takes place in the presence of additional oxidizing or reducing agents 
such as hydrogen peroxide (H2O2), 3-mercaptopropionic acid (MPA) and ascorbic 
acid (Sasmal et al., 2007). 
A massive number of oxidative DNA cleavage reagents have been utilized 
with great success for DNA foot-printing and as chemotherapeutic agents. There are 
some strong reductive agents act as inducing agents to produce radicals that are 
necessary being involved into the system of DNA cleavage reaction (Yang et al., 
2004a). The oxidative process results in either oxidation of nucleobases or 
degradation of sugar moiety by abstracting sugar hydrogen atom. Among four 
nucleobases, the guanine with purine base is the most susceptible for oxidation 
process (Patra et al., 2007; Rao et al., 2007; Sancheti et al., 2012). 
The interaction of these intermediates with the sugar moiety (Pogozelski & 
Tullius, 1998) or with nucleobases (Burrows & Muller, 1998) can result in direct 
strand cleavage or the formation of labile sites in the DNA. Besides these oxygen 
based intermediates, metal bound active intermediates are also known, such as 
intermediates in the catalytic cycle of iron bleomycin (vide infra). Figure 1.6 shows 
the proposed oxidative DNA cleavage mechanism of guanine by copper(II) complex 
in the presence of H2O2. 
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Figure 1.6: Proposed oxidative DNA cleavage mechanism of guanine by copper(II)  
        complex in the presence of H2O2 (Burrows & Muller, 1998) 
 
 
1.3 DNA interaction with transition metal complexes 
Since DNA is the basis for the storage, transmission and expression of 
genetic information, any reaction or damage caused to it will have important 
consequences. There has been a large interest in exploring the factors that determine 
kinship and selectivity in binding small molecules with DNA. A quantitative 
understanding of such factors that determine the recognition of DNA sites would be 
valuable in designing small molecules that binds to specific sites in DNA and applies 
it in chemotherapy. A number of metal chelates mostly polypyridyls have been used 
as probes of DNA structure in solution, as agents for mediation of strand scission of 
duplex DNA and as chemotherapeutic agents (Lippard, 1978; Hirohama et al., 2005). 
Cu(II) + e
-
 Cu(I) 
Cu(I) + O2 Cu(II) + O2ˉ
 
2O2ˉ + 2H
+
 O2 + H2O2 
Cu(I) + H2O2 Cu(II) + OHˉ + ·OH
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Transition metal complexes need to bind with DNA before they can cleave 
the DNA. Thus, there are several experimental techniques to determine the binding 
modes of complexes with DNA such as absorbance spectroscopy, fluorescent dye 
displacement assays, thermal stability, Scatchard analysis, viscometric titration, 
circular dichroism spectroscopy, electric linear dichroism, footprinting, fourier 
transform infrared spectroscopy, multi-dimensional nuclear magnetic resonance, X-
ray crystallography, confocal microscopy, Taq polymerase stop assay, and 
topoisomerase inhibition. The determination of the physical properties of DNA and 
small molecules is a practical tool as these properties change significantly with 
complex formation (Reddy et al., 1999). 
Basically, metal complexes could bind to DNA via covalent and non-covalent 
interactions (Patel et al., 2010a; Lakshmipraba et al., 2011). Covalent binding is 
irreversible and takes place when the metal complexes bind directly to one or more 
atoms, which are located at the surface of the DNA molecule. The replacement of 
labile ligand of metal complexes by a DNA nucleobase occurs in covalent binding 
with the coordination through guanine N7. Conversely, the non-covalent DNA 
interaction is reversible and takes place along the outer site of the DNA helix, either 
in major or minor groove. There are three different categories of non-covalent DNA 
interactions, which are intercalation, groove (surface) and electrostatic binding of 
cationic transition metal complexes (Peyratout et al., 1995; Ni et al., 2006; Kumar et 
al., 2007, 2009; Jia et al., 2010; Dixit et al., 2011). 
 
1.3.1 Intercalation 
The intercalation binding involves the insertion of a planar polycyclic 
aromatic ring system into a π-stack between two DNA base pair (Ihmels & Otto, 
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2005; Keene et al., 2009; Anbu & Kandaswamy, 2011a; Suntharalingam & Vilar, 
2011). Figure 1.7 demonstrates the example of an intercalation binding mode of 
ellipticine with DNA (Boer et al., 2009). There are several significant driving forces 
for this binding mode such as dipole-dipole interactions, electrostatic factors, π-
stacking and dispersive interactions of the guest molecules with the aromatic nucleic 
bases (Ihmels & Otto, 2005). The stacking interaction stabilizes this mode of binding 
and is thus less sensitive to the ionic strength relative to the other two binding modes. 
  
Figure 1.7: Intercalation binding of ellipticine with DNA (Boer et al., 2009) 
Metallointercalators has acquired an enormous interest since the interaction 
of DNA with aromatic ligands platinum complexes which is coplanar with metal 
coordination sites and has been reported by Howe-Grant and co-workers (Howe-
Grant & Lippard, 1979). Metallointercalators play an important role not only in 
probing nucleic acid structure and function but also in the intercalation process itself 
(Majumder et al., 2002).  
The ligands in the transition metal complexes are essential in the binding to 
DNA in which the aromatic moieties are able to enhance the DNA binding and 
cleavage activities. The presence of a large planar aromatic ligand such as 
DNA 
ellipticine 
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dipyrido[3,2-a;2’,3’-c]phenazine (dppz) of transition metal complex favours 
intercalation binding to DNA (Haq et al., 1995; Majumder et al., 2002; Rajalakshmi 
et al., 2011; Reddy & Raju, 2012). The intercalation binding to DNA by planar 
organic compounds was first proposed by Lerman (Lerman, 1961). Indeed with less 
extended aromatic systems, the intercalation is usually prevented through clashing of 
the ancillary ligands with the phosphodiester backbone, so that only partial 
intercalation can occur as in the case for [Ru(phen)3]
2+
 (Lincoln & Norden,1998). 
Besides the existence of planar aromatic ligands, solubility of the complex in water is 
also one of the desirable properties to act as a metallointercalator (Majumder et al., 
2002). 
 
1.3.2 Groove-binding 
There are two different sizes of grooves in DNA helix, the major and minor 
grooves, which provide binding sites for guest molecules. Examples of major groove 
binding by Δ-[Rh(byp)2chrysi]
3+
 (chrysi = 5,6-chrysenequinone diimine) (Sato & 
Yamagishi, 2007) to DNA and minor groove binding by distamycin (Boer et al., 
2009) to DNA are illustrated in Figure 1.8. Major groove-binding is preferred by 
relatively large molecules such as protein, while smaller ligands preferably bind to 
the minor groove binding sites (Ihmels & Otto, 2005). Non-planar ligands or ligands 
without extended planar aromatic system, particularly octahedral transition metal 
complexes, promote the groove binding with hydrogen bonding and π-π stacking 
interactions (Rajalakshmi et al., 2011; Suntharalingam & Vilar, 2011). 
Groove binding is the interaction of the molecules approach within van der 
Waals contact and reside in the DNA groove. Hydrophobic and hydrogen-bonding 
are usually important components of this binding process and provide stabilization. 
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Transition metal complex with at least two aromatic or heterocyclic rings are usually 
a groove binder. Minor groove binders may have some advantages compared to the 
major groove binder as they have been reported to exhibit excellent potential as 
therapeutic agents. Some examples of naturally occurring minor groove binders are 
Hoechst 33258, netropsin, distamycin and anthramycin (Mei & Barton, 1986; Reddy 
et al., 1999; Ihmels & Otto, 2005). 
  
  
Figure 1.8:  Major (a) and minor (b) groove binding with DNA (Sato & Yamagishi, 
2007; Boer et al., 2009) 
DNA 
Δ-[Rh(byp)2chrysi]
3+
 
distamycin 
(a) 
(b) 
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1.3.3 Electrostatic binding 
Electrostatic binding involves the complexes with positively charged and the 
DNA phosphate sugar backbone with negatively charged. This association mode was 
proposed for [Ru(byp)3]
2+
 (Figure 1.9), due to the luminescent enhancement of this 
complex upon binding to DNA. Cations such as Mg
2+
 usually interact in this way. 
 
Figure 1.9: Electrostatic binding by [Ru(byp)3]
2+
 to DNA 
 
1.4 Transition metal complexes 
In general, a transition metal complex is a substance that contains at least one 
complex ion, a species consisting of a centre transition metal cation that is 
coordinated to one or more ligands which displays diverse chemical, optical and 
magnetic properties. Coordination compounds are crucial in our lives; the study of 
them has contributed to the highest degree of understanding the chemical bond in 
inorganic chemistry. They play an important role in catalysis, material synthesis, 
photochemistry and biological systems. 
Transition metals are crucial in a huge number of widely differing biological 
processes. Some of these processes are quite unique in their metal ion requirements, 
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which only certain metal ions in specified oxidation states can achieve the necessary 
catalytic structural requirement. Metal ion dependent processes are found throughout 
the life science and vary tremendously in their function and complexity. It is now 
appreciated that metal ions control an enormous range of processes in biology. Many 
new and exciting developments in the field of biochemistry create interest out of 
inorganic chemists to court in the new area called “Bioinorganic Chemistry”. 
 
1.4.1 Biological and medicinal applications of transition metal complexes 
Transition metal complexes have attracted the attention of many researchers 
as they have a broad diversity of technological and industrial applications in wide 
ranging fields from material sciences to biological sciences. In the past century, the 
studies on DNA interactions by transition metal complexes were thought to be a 
peculiar choice and not so common (Sancheti et al., 2012). However, in the last few 
decades, the investigation on the interaction of transition metal complexes with DNA 
have become a dynamic area of research and acquired prominence owing to their 
significance in relation to the design and development of novel artificial nucleases 
for molecular biology, biotechnology and medicine (Wang et al., 2007; Kumar et al., 
2008b; Patel et al., 2010a; Raman & Selvan, 2011; Dong et al., 2011). 
The combination of toxicology, pharmacology, chemistry and biochemistry 
elements have caused medicinal inorganic chemistry to be regarded as a 
multidisciplinary field. Transition metal complexes possess marvellous potential that 
can be applied in genomic research, sequence specific binding of nucleic acids, 
footprinting studies and as diagnostic and therapeutic agents in medicinal industry. 
They are extensively used in clinical application as anticancer and antiviral agents 
due to their potential to comprise a class of chemotherapeutics (Brabec & Nováková, 
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2006; Patra et al., 2009a, 2009b; Arias et al., 2009; Chen et al., 2011). Metal 
complexes have been studied generally for these applications because of their 
electrochemical properties and distinctive spectroscopic. Besides that, another 
significant reason is that DNA binding and cleavage ability of a metal complex can 
be tuned by altering the ligand environment. This will enable the study of mechanism 
of the metal ion toxicity. (Raman et al., 2010a; Dong et al., 2011; Anbu & 
Kandaswamy, 2011a). 
These days, cancer has become the leading cause of death in most of the 
countries. Therefore, it is crucial to develop new anticancer therapies in medicinal 
chemistry. Transition metal complexes are renowned to stimulate drug action and the 
effectiveness of a therapeutic agent can always be enhanced against coordination 
with a metal ion. In addition, the pharmacological activity is not only highly relying 
on the nature of the metal ion but also the donor sequence of the ligands since 
different ligands show different biological properties (Khan et al., 2009). 
 
1.4.2 Platinum complexes 
In the year 1960s, Rosenberg discovered that platinum complexes were able 
to inhibit the division of bacterial cells (Rosenberg et al., 1965, 1969). Over the last 
decades, numerous coordination compounds especially platinum and ruthenium 
complexes are well-known to be anticancer agents. The very first transition metal 
anticancer drug was cisplatin [cis-diamminedichloroplatinum(II)], which is a metal 
coordination compound without any organic unit. It has become one of the most 
important drugs used for the treatment of cancer in modern medicine (Jaividhya et al., 
2012). The discovery of cisplatin has led to a great success in medicinal chemistry 
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due to its cytotoxicity and ability to bind to DNA covalently (Reddy et al., 2011; 
Ezadyar et al., 2012). 
From a biological and medicinal standpoint, the chemistry of platinum based 
complexes is very significant. For instance, some platinum complexes such as 
cisplatin, carboplatin and oxaliplatin are widely used as chemotherapeutic agents for 
the treatment of ovarian, testicular, lung, head, neck and colorectal cancers (Brabec 
& Nováková, 2006; Qiao et al., 2011; Patel et al., 2012). Schematic structures of 
cisplatin, carboplatin and oxaliplatin are illustrated in Figure 1.10. As 
chemotherapeutic agents, these platinum complexes crosslink the DNA strand in 
several different ways and subsequently interfere with the cell division by mitosis. 
The design and development of new complexes that are capable of interacting with 
nucleic acids and regulating apoptosis have become the favourable strategies for 
researchers to explore new anticancer drugs for chemotherapy (Qiao et al., 2011). 
Tu and co-workers synthesized and characterized two platinum(II) 2,2’-
dipyridylamine complexes with both chloride or 1,1-cyclobutanedicarboxylate as 
leaving groups. It is reported that both complexes could interact with DNA and the 
leaving groups of the complexes had minor effect on DNA interaction (Tu et al., 
2004). Very recently, Patel and co-workers prepared a series of cisplatin analogues 
of substituted 2,2’-bipyridines, where the complexes bind covalently to DNA and 
exhibit cytotoxic activity against brine shrimps (Patel et al., 2012). Some of the 
mixed ligand platinum(II) and palladium(II) complexes with amino acids have 
shown cytotoxicity against P388 lymphocytic leukemia cells and bonded to calf-
thymus DNA. They have been reported to be potential antitumor agents (Paul et al., 
1993; Jin & Ranford, 2000). 
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Figure 1.10: Schematic structures of cisplatin, carboplatin and oxaliplatin 
 
1.5 Medicinal applications and biological activities of copper(II) complexes 
Next to platinum complexes, copper complexes are one of the potential 
alternatives to cisplatin as antitumor drugs for chemotherapy. Copper is among the 
most extensively used transition metals and have found the possibility to be used in 
medicinal applications for the treatment of various diseases as well as cancer. Over 
the few decades, lots of inorganic chemists have explored copper(II) complexes due 
to their extraordinary anticancer activity and lower toxicity than platinum complexes 
(Patel et al., 2005; Barceló-Oliver et al., 2009; Dong et al., 2011; Jaividhya et al., 
2012). 
Copper is one of the most interesting bioessential trace elements present in 
animals and plants, but not in some microorganism with applicable oxidation states 
of +1 and +2. A number of important redox enzymes like hemocyanins, superoxide 
dismutase, blue copper proteins etc., contain copper atoms bound to protein 
molecules. It’s oxidative nature and biocompatible properties has gained interest 
from plenty of inorganic researchers to focus on copper(II) complexes in medicinal 
applications. Some low molecular weight copper(II) complexes have been proven 
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useful against numerous diseases such as gastric ulcers, rheumatoid, tuberculosis as 
well as cancer (Zhang et al., 2006a; Ni et al., 2006; Jia et al., 2010).  These bioactive 
compounds not only play a pivotal role in naturally occurring biological systems but 
were also used as pharmacological agents as well as potential anticancer or cancer 
inhibiting agents (García-Raso et al., 2003; Patel et al., 2006, 2010; Li et al., 2011; 
Jaividhya et al., 2012). The anticancer activity of several copper compounds have 
been screened and found to be active both in vitro and in vivo conditions 
(Ramakrishnan et al., 2009; Chen et al., 2010; Anbu et al., 2011b). 
An immense number of copper(II) complexes with different perspectives 
have been synthesized and their biological activities have been investigated due to 
the biological relevance of copper (Kumar et al., 2008b; Khan et al., 2009; Kumar & 
Arunachalam, 2009). Copper complexes were reported to produce significant 
pharmacological effect and act as a potential reagent for DNA cleavage in both 
oxidative and hydrolytic way with its biologically accessible redox potentials and 
high nucleobase affinity (Rajendiran et al., 2007; Reddy et al., 2011; Mohamed et al., 
2012).  Owing to the biological role and potential synergetic activity with the drugs, 
the development of copper(II) complexes has been explored widely into antibacterial, 
antiviral, antimicrobial, anti-inflammatory and anticancer agents (Lv et al., 2006; 
Fountoulaki et al., 2011; Lakshmipraba et al., 2011; Sousa et al., 2012; Chalkidou et 
al., 2012). 
Previous reports showed that many Schiff bases are known to be medicinally 
important and were used to design medicinal compounds. It was seen that the 
biological activity of Schiff bases was either increased or decreased upon chelation 
with metal ions. Bagihalli and co-workers prepared cobalt(II), nickel(II), and 
copper(II) complexes of Schiff bases derived from 3-substituted-4-amino-5-
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mercapto-1,2,4-triazole and 8-formyl-7-hydroxy-4-methylcoumarin which showed 
potent antibacterial activity against Escherichia coli, Staphylococcus aureus, 
Streptococcus pyogenes, Pseudomonas aeruginosa and Salmonella typhi and 
antifungal activities against Aspergillus niger, Aspergillus flavus and Cladosporium 
(Bagihalli et al., 2008). The structures of 1,2,4-triazole Schiff base in tautomeric 
form is depicted Figure 1.11. 
 
Figure 1.11: 1,2,4-triazole Schiff base in tautomeric form (Bagihalli et al., 2008) 
The biological activity of copper(II) and zinc(II) complexes with Schiff bases 
derived from pyrazole and semicarbazide or thiosemicarbazide (Figure 1.12) have 
been studied. The synthesized copper complexes binding with DNA through 
intercalation and photocleavage of plasmid DNA pBR322 was observed. The metal 
complexes displayed more efficient biological activity than the free ligands (Raman 
et al., 2010b). Sabolová and co-workers prepared a series of copper(II) complexes 
containing Schiff base derived from salicylaldehyde, and the interaction with calf-
thymus has been investigated. The complexes have showed to have intercalative 
binding with DNA which increased the antimicrobial effect more than 60 times 
against Candida albicans in the presence of ascorbic acid (Sabolová et al., 2011). 
 
22 
 
 
R1 = OCH3, OH; R2 = OCH3, NO2; X = O, S 
Figure 1.12: Schiff bases structure of pyrazole and semicarbazide/thiosemicarbazide  
          (Raman et al., 2010b) 
Recently, a new Schiff base ligand, (2-amino-3-((2-hydroxy-1-
phenylethylimino)methyl)-4H-chromen-4-one, and its chiral complexes (Figure 1.13) 
containing copper(II) and zinc(II) have been developed by Arjmand group. Both of 
these complexes bind to calf-thymus DNA via electrostatic groove binding mode. 
Such copper(II) complex has been observed to promote efficient DNA cleavage with 
pBR322 DNA in the presence of different activators (Arjmand et al., 2011). 
 
Figure 1.13:  Copper(II) (a) and zinc(II) (b) complexes of (2-amino-3-((2-hydroxy-
1-phenylethylimino)methyl)-4H-chromen-4-one (Arjmand et al., 2011) 
 
 
(a) (b) 
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1.5.1 Copper(II) complexes of amino acids and its biological applications 
Amino acids are biologically important molecules that consist of amino (-
NH2) and carboxyl (-COOH) functional groups, attach with a specific side-chain to 
each amino acid. Amino acids that comprising of both the amine and carboxylic acid 
group attached to the first carbon atom which is significant in biochemistry field. 
Amino acids are the basic structural units of peptides (short polymer chains) or 
proteins (long polymer chains) that recognize a specific base sequence of DNA by 
way of hydrogen bond formation (Harada et al., 1996; Kumar & Arunachalam, 2009). 
The chemical properties of the amino acids are essential in performing an enormous 
number of biological functions (Stanila et al., 2007; Neelakantan et al., 2008). 
Proteins not only catalyze most of the reactions in living cells, but also control 
virtually all cellular processes. 
Amino acids which are found in the human body are categorized as essential, 
non-essential, and conditional amino acids are illustrated in Table 1.1. The naturally 
occurring amino acids are all in L-form, and the chirality of the side groups is crucial 
in the specific interaction between the protein and DNA (Chikira et al., 1997). 
Table 1.1: Category of amino acids in human body 
Essential amino acids 
Histidine, Isoleucine, Leucine, Lysine, Methionine, 
Phenylalanine, Threonine, Tryptophan, Valine 
Non-essential amino 
acids 
Alanine, Asparagine, Aspartic acid, Glutamic acid, 
Glycine 
Conditional amino 
acids 
Arginine, Cysteine, Glutamine, Ornithine, Proline, 
Selenocysteine, Serine, Taurine, Tyrosine  
 
Copper(II) complexes with amino acids are known to have potent anti-ulcer 
activity and anti-inflammatory activities. Earlier reports have exemplified that 
copper(II) complexes with amino acid or peptide base exhibit good DNA cleavage 
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activity through oxidative and hydrolytic pathways (Rao et al., 2008). Apart from 
that, they also show strong superoxide dismutase (SOD) activity (Li et al., 2005). 
Peptides contain various potential donor centres and act as an effective ligand for 
many transition metal ions (Tiliakos et al., 2003). 
Several reports revealed that first-row transition metal complexes of amino 
acid Schiff bases also exhibit various biological activities such as antiviral, 
antitubercular, antifungi and antibacterial activities (Dong et al., 2011). Reddy and 
co-workers investigated the DNA binding and cleavage abilities of two copper(II) 
complexes with histamine and amino acids. Both complexes are observed to bind 
with calf-thymus DNA in intercalative mode with intrinsic binding constants of 2.2-
2.7 × 10
2
 M
-1
 and cleave plasmid pUC19 DNA (Reddy et al., 2006). 
 
1.5.2 Copper(II) complexes of polypyridyl ligands and its biological 
applications 
Literature reports revealed that an immense number of copper(II) complexes 
have found to be more active with drugs in the presence of heterocyclic nitrogen 
donor ligands and gained prominence due to their special electronic properties, 
peculiar structure and diverse chemical reactivity which result in non-covalent 
interaction with DNA (Lv et al., 2006; Barve et al., 2009; Dey et al., 2010; Patel et 
al., 2010b; Chen et al., 2011). Numerous polypyridyl based transition metal 
complexes have been developed over the past few decades for the application as non-
radioactive nucleic acid probes and DNA cleaving agents (Hirohama et al., 2005; 
Anbu et al., 2011b). 
